The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions. PPTA works globally to: Advocate for access to and affordability of therapies for patients, engage in constructive dialogue with regulatory agencies, and collaborate with patient advocacy organizations
Shared 3 weeks ago
4 views
Shared 1 month ago
4 views
Shared 1 month ago
1 view
Shared 1 month ago
13 views
Shared 1 month ago
5 views
Shared 1 month ago
2 views
Shared 1 month ago
0 views
Shared 1 month ago
53 views
Shared 1 month ago
13 views
Shared 1 month ago
18 views
Shared 2 months ago
9 views
Shared 4 months ago
15 views
Shared 4 months ago
58 views
Shared 4 months ago
27 views
Shared 4 months ago
30 views
Shared 4 months ago
10 views
Shared 4 months ago
21 views
Shared 4 months ago
16 views
Shared 4 months ago
7 views
Shared 5 months ago
4 views
Shared 5 months ago
9 views
Shared 7 months ago
97 views
Shared 7 months ago
46 views
Shared 9 months ago
81 views
Shared 10 months ago
505 views
Shared 10 months ago
104 views
Shared 10 months ago
110 views
Shared 10 months ago
121 views
Shared 10 months ago
202 views
Shared 1 year ago
209 views
Shared 1 year ago
33 views
Shared 1 year ago
181 views
Shared 1 year ago
102 views
Shared 1 year ago
214 views
Shared 1 year ago
87 views
Shared 1 year ago
46 views
Shared 1 year ago
78 views
Shared 1 year ago
38 views
Shared 1 year ago
108 views